Soluble HLA class I and class II concentrations in commercial immunoglobuh preparations
- 1 February 1992
- journal article
- Published by Wiley in Tissue Antigens
- Vol. 39 (2) , 74-77
- https://doi.org/10.1111/j.1399-0039.1992.tb01910.x
Abstract
Soluble HLA class I (sHLA-ABC) and class II (sHLA-RQP) molecules were quantitated in 16 commercially available immunoglobulin (Ig) preparations by enzyme-linked immunosorbent assays. Whereas three Ig preparations contained no detectable sHLA-ABC, all preparations showed concomitant sHLA-RQP molecules. There was a considerable variability with regard to the individual sHLA concentrations. For sHLA-RQP the values exceeded that found in human plasma of healthy individuals, suggesting that the extraction procedure may concentrate not only Ig, but also HLA class II molecules. Based on the total dosage of intravenously administered immunoglobulins (i.v.Ig), contaminating sHLA molecules may become immunogenic. Furthermore, sHLA molecules are discussed in terms of participation in the well-known immuno-modulating effects of i.v.Ig therapy.Keywords
This publication has 35 references indexed in Scilit:
- Antiidiotypic antibodies to HLA class I alloantibodies in normal individuals: A mechanism of tolerance to noninherited maternal HLA antigensHuman Immunology, 1991
- SOLUBLE HLA ANTIGENS, ANTI-HLA ANTIBODIES, AND ANTIIDIOTYPIC ANTIBODIES IN THE CIRCULATION OF RENAL TRANSPLANT RECIPIENTSTransplantation, 1991
- Cellular signalling in programmed cell death (apoptosis)Immunology Today, 1990
- Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies.Journal of Clinical Investigation, 1990
- THE USE AND MECHANISMS OF ACTION OF INTRAVENOUS IMMUNOGLOBULIN: AN UPDATEBritish Journal of Haematology, 1989
- Association between HLA phenotype and HLA concentration in plasma or plateletsHuman Immunology, 1988
- Treatment of Antibody-Mediated Pure Red-Cell Aplasia with High-Dose Intravenous Gamma GlobulinNew England Journal of Medicine, 1987
- Two forms of HLA class I molecules in human plasmaHuman Immunology, 1987
- Treatment of Refractory Immune Thrombocytopenic Purpura with an Anti-Fcγ-Receptor AntibodyNew England Journal of Medicine, 1986
- INTRAVENOUS IMMUNOGLOBULIN VERSUS ORAL CORTICOSTEROIDS IN ACUTE IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDHOODThe Lancet, 1985